🇺🇸 Glucophage 1000 mg in United States

18 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 18

Most-reported reactions

1. Acute Kidney Injury — 4 reports (22.22%)
2. Dyspnoea — 2 reports (11.11%)
3. Epithelioid Mesothelioma — 2 reports (11.11%)
4. Fall — 2 reports (11.11%)
5. Headache — 2 reports (11.11%)
6. Injury — 2 reports (11.11%)
7. Acute Respiratory Failure — 1 report (5.56%)
8. Anaphylactic Shock — 1 report (5.56%)
9. Antipsychotic Drug Level — 1 report (5.56%)
10. Atrial Fibrillation — 1 report (5.56%)

Source database →

Frequently asked questions

Is Glucophage 1000 mg approved in United States?

Glucophage 1000 mg does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Glucophage 1000 mg in United States?

Sandoz is the originator. The local marketing authorisation holder may differ — check the official source linked above.